RACHEL BENNEFIELD: Open Payments
NPI 1760028856 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 29 payments from 11 companies in 2025. Trend: 2023 $438 · 2024 $565 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $101 |
| Seqirus USA Inc | 5 | $92 |
| ABBVIE INC. | 4 | $91 |
| PFIZER INC. | 4 | $73 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $57 |
| Lilly USA, LLC | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: Flucelvax, CREON, Wegovy, XIFAXAN, Ozempic, ELIQUIS, AIRSUPRA, KISUNLA.
Industry payments across GA — which companies pay providers there.
